LC
Therapeutic Areas
Orbsen Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ORBCEL™ for Diabetic Kidney Disease (NEPHSTROM Trial) | Diabetic Kidney Disease (DKD) | Phase 2 |
| ORBCEL™ for ARDS | Acute Respiratory Distress Syndrome (including COVID-19 related) | Phase 1/2 |
| ORBCEL™ for Diabetic Foot Ulcers | Diabetic Foot Ulcers (DFU) | Pre-clinical/Research |
| ORBCEL™ for Primary Sclerosing Cholangitis | Primary Sclerosing Cholangitis (PSC) | Pre-clinical/Research |